J. E. Degener

2.7k citations

59 papers · 2.1k indexed · h-index 28

Applied Microbiology and Biotechnology top 0.2%
- Antibiotic Use and Resistance 9
Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 17
Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 15
Endocrinology top 2%
Microbiology top 2%
Infectious Diseases
- Antimicrobial Resistance in Staphylococcus 10
Epidemiology
- Pneumonia and Respiratory Infections 9
- Infective Endocarditis Diagnosis and Management 9
Pharmacology
- Antibiotics Pharmacokinetics and Efficacy 9
Public Health, Environmental and Occupational Health
- Streptococcal Infections and Treatments 5

Co-authors: G.W. Welling A.C.M. Veloo Marc Michel Hermie J. M. Harmsen Dominique L. Monnet Larissa Grigoryan J. Birkin F. M. Haaijer-Ruskamp
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Clinical Biochemistry
Journals: Journal of Antimicrobial Chemotherapy (7 papers)Clinical Microbiology and Infection (5 papers)European Journal of Clinical Microbiology & Infectious Diseases (5 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

J. E. Degener

58 papers receiving 1.9k citations

Peers

Countries citing papers authored by J. E. Degener

Since Specialization

Citations

This map shows the geographic impact of J. E. Degener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. E. Degener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. E. Degener more than expected).

Fields of papers citing papers by J. E. Degener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. E. Degener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. E. Degener. The network helps show where J. E. Degener may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. E. Degener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. E. Degener Line = papers co-authored together J. E. Degener links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Assessment of the microbiota of a mixed infection of the tongue using phenotypic and genotypic methods simultaneously and a review of the literature Anaerobe ·A.C.M. Veloo,Rutger H. Schepers,G.W. Welling,J. E. Degener	2011	4
2	Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009 Eurosurveillance ·Carlo Gagliotti,Arta Balode,Fernando Baquero,J. E. Degener,Hajo Grundmann,Deniz Gür,Vincent Jarlier,Gunnar Kahlmeter,J. Monen,Dominique L. Monnet,Gian María Rossolini,C. Suetens,K. Weist,Ole Eske Heuer,Cocheme HM	2011	147
3	Is bacteriologic surveillance in endoscope reprocessing stringent enough? Endoscopy ·Julia Kovaleva,N.E.L. Meessen,Femke P. Peters,Martin Been,Jan P. Arends,Bernd Bischl,J. E. Degener	2009	61
4	Endoscope disinfection and its pitfalls - requirement for retrograde surveillance cultures Endoscopy ·L.L. Leenders,Martin Been,Bernd Bischl,I. Stokroos,Willem J. G. Melchers,Femke P. Peters,立丰孟,J. E. Degener	2008	49
5	Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system Journal of Antimicrobial Chemotherapy ·Larissa Grigoryan,Johannes G. M. Burgerhof,J. E. Degener,Reginald Deschepper,Cecilia Stålsby Lundborg,Dominique L. Monnet,Elizabeth Scicluna,J. Birkin,F. M. Haaijer-Ruskamp	2008	171
6	Effect of Hospitalization on the Antibiotic Resistance of Fecal Enterococcus faecalis of Surgical Patients Over Time Microbial Drug Resistance ·S. Nys,Nienke Bruinsma,P. Margreet G. Filius,A. E. van den Bogaard,Lorraine J. Hoffman,Hardian Rifanza,A. C. M. Wildeboer-Veloo,J. E. Degener,Hubert P. Endtz,Ellen E. Stobberingh	2005	7
7	Denaturing gradient gel electrophoresis analysis to study bacterial community structure in pockets of periodontitis patients Oral Microbiology and Immunology ·Vincent Zijnge,Hermie J. M. Harmsen,Catalina Gonzales Aviles,Michel E. van der Rest,J. E. Degener,G.W. Welling	2003	61
8	Antibiotic Usage and Resistance in Different Regions of the Dutch Community Microbial Drug Resistance ·Nienke Bruinsma,P. Margreet G. Filius,Peter A. G. M. De Smet,J. E. Degener,Julie Ann Perreault,A. E. van den Bogaard,Ellen E. Stobberingh	2002	15
9	Implications of the Simultaneous Presence of Metronidazole-Susceptible and -Resistant Helicobacter pylori Colonies Within a Single Biopsy Specimen European Journal of Clinical Microbiology & Infectious Diseases ·N. L. A. Arents,Leonard C. Smeets,Anton A. van Zwet,J C Thijs,E.J. van der Wouden,Alwin de Jong,J. E. Degener,Johannes G. Kusters	2001	13
10	Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS)† Clinical Microbiology and Infection ·Wim Goettsch,S L A M Bronzwaer,Albert J. de Neeling,候江伟,H. Aubry‐Damon,B Olsson-Liljequist,M Sprenger,J. E. Degener	2000	20
11	Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis Journal of Hospital Infection ·R.M. Khavula,Gerda T. Noordhoek,H. G. J. Voesten,Lucie DAVÍDKOVÁ,J. E. Degener	1999	63
12	Slime-producing properties of coagulase-negative staphylococci isolated from blood cultures Clinical Microbiology and Infection ·В Ю Тополевский,J. E. Degener	1998	15
13	16S Ribosomal RNA-Targeted Oligonucleotide Probes for Monitoring of Intestinal Tract Bacteria Scandinavian Journal of Gastroenterology ·G.W. Welling,Peter Elfferich,Wendy Ilisandra Zatti,A. C. M. Wildeboer-Veloo,Gijsbert J. Jansen,J. E. Degener	1997	41
14	Microbiology of Chronic Maxillary Sinusitis in Adults: Isolated Aerobic and Anaerobic Bacteria and their Susceptibility to Twenty Antibiotics Acta Oto-Laryngologica ·Kiana Kerynne Olanes,J. E. Degener,Peter Paul G. van Benthem,G.J. Hordijk	1995	29
15	Breakpoint determination: Sparfloxacin European Journal of Clinical Microbiology & Infectious Diseases ·Ian Phillips,J. F. Acar,Fernando Baquero,David J. Downey,J. E. Degener,Arne Forsgren,Gian Carlo Schito,B. Wiedemann	1994	7
16	Pericarditis, pneumonia and brain abscess due to a combined Actinomyces—Actinobacillus actinomycetemcomitans infection Journal of Infection ·E.E. Zijlstra,GABRIELLA VASCONCELLOS BIAZUS,Nurfina J. Pelu,J. E. Degener	1992	45
17	Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci Journal of Antimicrobial Chemotherapy ·R. P. Mouton,J. Hermans,A. M. Simoons‐Smit,J. A. A. Hoogkamp‐Korstanje,J. E. Degener,B. van Klingeren	1990	45
18	Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis Journal of Medical Microbiology ·A. M. Horrevorts,Jannie Borst,Jae-hyun Noh,Rogier de Ridder,孙明贵,J. E. Degener,K. F. Kerrebijn,Jochen Wehmann	1990	16
19	Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection Cancer ·M. C. Kappers‐Klunne,J. E. Degener,Theo Stijnen,J. Abels	1989	80
20	Typing ofAcinetobacter calcoaceticusstrains isolated from hospital patients by cell envelope protein profiles Epidemiology and Infection ·Lenie Dijkshoorn,Wim van Vianen,J. E. Degener,Marc Michel	1987	46

About J. E. Degener

J. E. Degener is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Microbiology and Infectious Diseases, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (17 papers), Bacterial Identification and Susceptibility Testing (15 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Pneumonia and Respiratory Infections (9 papers), Antibiotic Use and Resistance (9 papers), Infective Endocarditis Diagnosis and Management (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Streptococcal Infections and Treatments (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (439 citations), Molecular Medicine (376 citations), Clinical Biochemistry (481 citations), Endocrinology (185 citations) and Microbiology (215 citations). J. E. Degener has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include G.W. Welling, A.C.M. Veloo, Marc Michel, Hermie J. M. Harmsen, Dominique L. Monnet, Larissa Grigoryan, J. Birkin, F. M. Haaijer-Ruskamp, Elizabeth Scicluna and Johannes G. M. Burgerhof. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Clinical Microbiology and Eurosurveillance.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact